Floatz logo

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT

Hodgkins Lymphoma

Fred Hutchinson Cancer Centerother_biologicalPhase 2Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
65/ 100

Competitive context

140 Active assets in the Hodgkins Lymphoma cohort.

Asset / SponsorPhaseRating
Everolimus
OHSU Knight Cancer Institute
Phase 2BBB
Camustine
VIVUS LLC
Phase 2BBB
METHOTREXATE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
Carboplatin
St. Petersburg State Pavlov Medical University
Phase 2BBB
Cyclosporin A
City of Hope Medical Center
Phase 3BBB

View all 50 →

Same molecule, other indications

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT is also rated in:

myelodysplastic/myeloproliferative neoplasmActive
BBB
Indicative · Phase 2/3
75 / 100
View asset →
plasma cell myelomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →
myeloproliferative neoplasmActive
BB
Indicative · Phase 2/3
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →